Vimarsana
Biggest News Aggregation in the World

Antigen System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antigen System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antigen System Today - Breaking & Trending Today

Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil - Vimarsana News

Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil

Share: HAUPPAUGE, N.Y., July 20, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of a $28.3 million purchase order from Bio-Manguinhos for the purchase of Chembio's DPP SARS-CoV-2 Antigen tests for delivery during 2021 to support the urgent needs of Brazil's Ministry of Health in addressing the COVID-19 pandemic. The DPP SARS-CoV-2 Antigen test is designed to detect the SARS-CoV-2 antigen, which indicates an active COVID-19 infection, in only 20 minutes using a minimal...

Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil - Vimarsana News

Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil

Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil HAUPPAUGE, N.Y., July 20, 2021 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of a $28.3 million purchase order from Bio-Manguinhos for the purchase of Chembio’s DPP SARS-CoV-2 Antigen tests for delivery during 2021 to support the urgent needs of Brazil’s Ministry of Health in addressing the COVID-19 pandemic. The DPP SARS-CoV-2 Antigen test is desig...

Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR - Vimarsana News

Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR

( B) Schematic of the GP gene transcription profile. ( C) Binding of scFv-phage clones to EBOV sGP measured using Ag-down ELISA. Each data point is N = 1 technical replicate for scFv-phage clones with a distinct sequence. a.u., arbitrary units. ( D) Binding of six scFv-Fc Abs to sGP, measured using Ag-down ELISA. Each data point represents the mean ± SEM of N = 2 replicates. ( E) Schematic of Ab pairing using the D4 assay. (i) cAb and FL-dAb printed onto POEGMA-coated glass are exposed to sGP-spiked sample. (ii) Fluorescent spots are imaged; insets show spots with high (white) and low (red...

Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results - Vimarsana News

Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results

Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the

Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems - Vimarsana News

Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com